Journal article
Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18
Authors
Douillard J; Petersen V; Shepherd F; Paz-Ares L; Arnold A; Tonato M; Ottaway J; Davis M; Van Vreckem A; Humphrey J
Journal
European Journal of Cancer, Vol. 37, , pp. s19–s20
Publisher
Elsevier
Publication Date
April 1, 2001
DOI
10.1016/s0959-8049(01)80555-4
ISSN
0959-8049